EMA Authorised: Opsumit (macitentan) — Janssen-Cilag International N.V.

View source ↗

Summary

EMA authorised Opsumit (macitentan) by Janssen-Cilag International N.V. for pulmonary arterial hypertension. This marks EU authorization of the medicine for thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• OPSUMIT (macitentan)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Janssen-Cilag International N.V.. Decision date: 23/04/2026